Latest News and Press Releases

Plus Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Plus Therapeutics Presents Positive Clinical Trial Results at the 2024 SNO/ASCO CNS Metastases Conference

Plus Therapeutics Presents Positive Interim ReSPECT-LM Phase 1 Data for Leptomeningeal Metastases at 2024 SNO/ASCO CNS Metastases Conference

Plus Therapeutics to Announce Second Quarter Financial Results and Host Conference Call on August 14, 2024

Plus Therapeutics Showcases Leptomeningeal Metastases Programs at 2024 SNO/ASCO Conference

Plus Therapeutics to Present at the Gordon Research Conference Radionuclide Theranostics for the Management of Cancer

Plus Therapeutics Expands Management Team and Reports $3.3M Advance Payment from CPRIT

Plus Therapeutics Announces New Employment Inducement Grants

Plus Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

Plus Therapeutics to Announce First Quarter Financial Results and Host Conference Call on May 15, 2024